SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Arun J. Sanyal, Scott L. Friedman, Arthur J. McCullough, Lara Dimick-Santos, Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases–U.S. Food and Drug Administration Joint Workshop, Hepatology, 2015, 61, 4
  2. 2
    Kohei Oda, Hirofumi Uto, Seiichi Mawatari, Akio Ido, Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies, Clinical Journal of Gastroenterology, 2015, 8, 1, 1

    CrossRef

  3. 3
    Niraj S. Patel, Iliana Doycheva, Michael R. Peterson, Jonathan Hooker, Tatiana Kisselva, Bernd Schnabl, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba, Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis, Clinical Gastroenterology and Hepatology, 2015, 13, 3, 561

    CrossRef

  4. 4
    Mazen Noureddin, Mary E. Rinella, Etiology (ii) Fatty Liver Disease, Clinics in Liver Disease, 2015,

    CrossRef

  5. 5
    Stuart McPherson, Tim Hardy, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee, Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management, Journal of Hepatology, 2015, 62, 5, 1148

    CrossRef

  6. 6
    A. Martini, G. Fattovich, M. Guido, E. Bugianesi, A. Biasiolo, D. Ieluzzi, A. Gallotta, G. Fassina, C. Merkel, A. Gatta, F. Negro, P. Pontisso, HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients, Journal of Viral Hepatitis, 2015, 22, 5
  7. 7
    Amanda Tamar Schneier, Caitlin Colleen Citti, Douglas T Dieterich, Management and diagnosis of fatty liver disease, Expert Review of Gastroenterology & Hepatology, 2015, 1

    CrossRef

  8. 8
    C. G. Morse, M. McLaughlin, L. Matthews, M. Proschan, F. Thomas, A. M. Gharib, M. Abu-Asab, A. Orenstein, R. E. Engle, X. Hu, R. Lempicki, C. Hadigan, D. E. Kleiner, T. Heller, J. A. Kovacs, Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy, Clinical Infectious Diseases, 2015,

    CrossRef

  9. 9
    Jiayun Shen, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Ruth Suk-Mei Chan, Hoi-Yun Chan, Winnie Chiu-Wing Chu, Bernice Ho-Ki Cheung, David Ka-Wai Yeung, Liz Sin Li, Mandy Man-Mei Sea, Jean Woo, Vincent Wai-Sun Wong, PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease, Journal of Gastroenterology and Hepatology, 2015, 30, 1
  10. 10
    Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hiroyoshi Taketani, Kazuyuki Kanemasa, Hiroshi Ishiba, Akira Okajima, Takeshi Nishimura, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Masahito Minami, Yoshito Itoh, Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease, Hepatology Research, 2015, 45, 4
  11. 11
    Chun-Yan Song, Xin Zeng, Yang Wang, Jian Shi, Hui Qian, Yi Zhang, Jia-Qing Fang, Xia Sheng, Jian-Ming Zheng, Yue-Xiang Chen, Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis, Journal of Gastroenterology and Hepatology, 2015, 30, 2
  12. 12
    Hannah E. Da Silva, Bianca M. Arendt, Seham A. Noureldin, George Therapondos, Maha Guindi, Johane P. Allard, A Cross-Sectional Study Assessing Dietary Intake and Physical Activity in Canadian Patients with Nonalcoholic Fatty Liver Disease vs Healthy Controls, Journal of the Academy of Nutrition and Dietetics, 2014, 114, 8, 1181

    CrossRef

  13. 13
    Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, Deepak Amarapurkar, Chhagan Bihari, Albert C. Chan, Yogesh Kumar Chawla, A. Kadir Dokmeci, Hitendra Garg, Hasmik Ghazinyan, Saeed Hamid, Dong Joon Kim, Piyawat Komolmit, Suman Lata, Guan Huei Lee, Laurentius A. Lesmana, Mamun Mahtab, Rakhi Maiwall, Richard Moreau, Qin Ning, Viniyendra Pamecha, Diana Alcantara Payawal, Archana Rastogi, Salimur Rahman, Mohamed Rela, Anoop Saraya, Didier Samuel, Vivek Saraswat, Samir Shah, Gamal Shiha, Brajesh Chander Sharma, Manoj Kumar Sharma, Kapil Sharma, Amna Subhan Butt, Soek Siam Tan, Chitranshu Vashishtha, Zeeshan Ahmed Wani, Man-Fung Yuen, Osamu Yokosuka, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014, Hepatology International, 2014, 8, 4, 453

    CrossRef

  14. 14
    Masanori Abe, Teruki Miyake, Atsushi Kuno, Yasuharu Imai, Yoshiyuki Sawai, Keisuke Hino, Yuichi Hara, Shuhei Hige, Michiie Sakamoto, Gotaro Yamada, Masayoshi Kage, Masaaki Korenaga, Yoichi Hiasa, Masashi Mizokami, Hisashi Narimatsu, Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease, Journal of Gastroenterology, 2014,

    CrossRef

  15. 15
    P. Loria, G. Marchesini, F. Nascimbeni, S. Ballestri, M. Maurantonio, F. Carubbi, V. Ratziu, A. Lonardo, Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology, Atherosclerosis, 2014, 232, 1, 99

    CrossRef

  16. 16
    Min Young Rim, Oh Sang Kwon, Minsu Ha, Ju Seung Kim, Kwang Il Ko, Dong Kyu Kim, Pil Kyu Jang, Jung Yoon Han, Pyung Hwa Park, Young Kul Jung, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim, Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma, The Korean Journal of Gastroenterology, 2014, 63, 5, 292

    CrossRef

  17. 17
    Dina L. Halegoua-De Marzio, Jonathan M. Fenkel, Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease, Advances in Hepatology, 2014, 2014, 1

    CrossRef

  18. 18
    Abigale Lade, Luke A. Noon, Scott L. Friedman, Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer, Current Opinion in Oncology, 2014, 26, 1, 100

    CrossRef

  19. 19
    Julie Heimbach, Debate: A bridge too far—liver transplantation for nonalcoholic steatohepatitis will overwhelm the organ supply, Liver Transplantation, 2014, 20, S2
  20. 20
    Honghui Guo, Ruimin Zhong, Yongji Liu, Xinwei Jiang, Xilan Tang, Zhen Li, Min Xia, Wenhua Ling, Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease, Nutrition, 2014, 30, 2, 198

    CrossRef

  21. 21
    Vincent Wai-Sun Wong, Grace Lai-Hung Wong, David Ka-Wai Yeung, Jill M Abrigo, Alice Pik-Shan Kong, Ruth Suk-Mei Chan, Angel Mei-Ling Chim, Jiayun Shen, Chung-Shun Ho, Jean Woo, Winnie Chiu-Wing Chu, Henry Lik-Yuen Chan, Fatty Pancreas, Insulin Resistance, and β-Cell Function: A Population Study Using Fat-Water Magnetic Resonance Imaging, The American Journal of Gastroenterology, 2014, 109, 4, 589

    CrossRef

  22. 22
    Ricardo Badillo, Don C. Rockey, Hepatic Hydrothorax, Medicine, 2014, 93, 3, 135

    CrossRef

  23. 23
    Cory M. Fielding, Paul Angulo, Hepatic Steatosis and Steatohepatitis: Are they Really Two Distinct Entities?, Current Hepatology Reports, 2014, 13, 2, 151

    CrossRef

  24. 24
    Glenn S. Gerhard, Peter Benotti, G. Craig Wood, Xin Chu, George Argyropoulos, Anthony Petrick, William E. Strodel, Jon D. Gabrielsen, Anna Ibele, Christopher D. Still, Christopher Kingsley, Johanna DiStefano, Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity, Journal of Obesity, 2014, 2014, 1

    CrossRef

  25. 25
    Geoffrey Farrell, Insulin Resistance, Obesity, and Liver Cancer, Clinical Gastroenterology and Hepatology, 2014, 12, 1, 117

    CrossRef

  26. 26
    Jae Youn Cheong, Is It Necessary for NAFLD Patients to be Screened for Hepatocellular Carcinoma?, The Korean Journal of Gastroenterology, 2014, 63, 5, 265

    CrossRef

  27. 27
    Ester Vanni, Lavinia Mezzabotta, Elisabetta Bugianesi, NAFLD and Hepatocellular Carcinoma: How Big a Problem is This Really?, Current Hepatology Reports, 2014, 13, 2, 113

    CrossRef

  28. 28
    Ijin Joo, Jeong Min Lee, Jeong Hee Yoon, Ja Jun Jang, Joon Koo Han, Byung Ihn Choi, Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging—An Experimental Study in a Rabbit Model, Radiology, 2014, 270, 1, 131

    CrossRef

  29. 29
    Ja Kyung Kim, Kwan Sik Lee, Dong Ki Lee, Su Yeon Lee, Hye Young Chang, Junjeong Choi, Jung Il Lee, Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice, Experimental & Molecular Medicine, 2014, 46, 12, e127

    CrossRef

  30. 30
    Takemi Rokugawa, Tomoya Uehara, Yusuke Higaki, Shuuichi Matsushima, Atsushi Obata, Yasushi Arano, Kohji Abe, Potential of 99mTc-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice, EJNMMI Research, 2014, 4, 1, 57

    CrossRef

  31. 31
    Lynn H. Gerber, Ali Weinstein, Lisa Pawloski, Role of Exercise in Optimizing the Functional Status of Patients with Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2014, 18, 1, 113

    CrossRef

  32. 32
    Paola Portillo, Sahzene Yavuz, Fernando Bril, Kenneth Cusi, Role of Insulin Resistance and Diabetes in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease, Current Hepatology Reports, 2014, 13, 2, 159

    CrossRef

  33. 33
    Stuart McPherson, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee, Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease, Journal of Hepatology, 2014, 60, 5, 1055

    CrossRef

  34. 34
    Csilla Balassy, Diana Feier, Markus Peck-Radosavljevic, Friedrich Wrba, Stephan Witoszynskyj, Berthold Kiefer, Gert Reiter, Yongming Dai, Ahmed Ba-Ssalamah, Susceptibility-weighted MR Imaging in the Grading of Liver Fibrosis: A Feasibility Study, Radiology, 2014, 270, 1, 149

    CrossRef

  35. 35
    R. Kwok, Y.-K. Tse, G. L.-H. Wong, Y. Ha, A. U. Lee, M. C. Ngu, H. L.-Y. Chan, V. W.-S. Wong, Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin-18 fragments, Alimentary Pharmacology & Therapeutics, 2014, 39, 3
  36. 36
    Noa Mashav, Oren Shibolet, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  37. 37
    Vincent Wai-Sun Wong, Ruth Suk-Mei Chan, Grace Lai-Hung Wong, Bernice Ho-Ki Cheung, Winnie Chiu-Wing Chu, David Ka-Wai Yeung, Angel Mei-Ling Chim, Jennifer Wing-Yan Lai, Liz Sin Li, Mandy Man-Mei Sea, Francis Ka-Leung Chan, Joseph Jao-Yiu Sung, Jean Woo, Henry Lik-Yuen Chan, Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial, Journal of Hepatology, 2013, 59, 3, 536

    CrossRef

  38. 38
    Sahil Mittal, Hashem B. El-Serag, Epidemiology of Hepatocellular Carcinoma, Journal of Clinical Gastroenterology, 2013, 47, S2

    CrossRef

  39. 39
    Yuan Tian, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Alfred Sze-Lok Cheng, Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease, Seminars in Cancer Biology, 2013, 23, 6, 471

    CrossRef

  40. 40
    Hongbin Zhu, Kongming Wu, Wenji Yan, Ling Hu, Jing Yuan, Yan Dong, Yazhuo Li, Kunyu Jing, Yunsheng Yang, Mingzhou Guo, Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma, Hepatology, 2013, 58, 6
  41. 41
    Ramesh Kumar, Hard clinical outcomes in patients with NAFLD, Hepatology International, 2013, 7, S2, 790

    CrossRef

  42. 42
    Niraj S. Patel, Michael R. Peterson, Grace Y. Lin, Ariel Feldstein, Bernd Schnabl, Ricki Bettencourt, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba, Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls, Gastroenterology Research and Practice, 2013, 2013, 1

    CrossRef

  43. 43
    Christoph Jüngst, Thomas Berg, Jun Cheng, Richard M. Green, Jidong Jia, Andrew L. Mason, Frank Lammert, Intrahepatic cholestasis in common chronic liver diseases, European Journal of Clinical Investigation, 2013, 43, 10
  44. 44
    Geoffrey C. Farrell, Vincent Wai-Sun Wong, Shiv Chitturi, NAFLD in Asia—as common and important as in the West, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 5, 307

    CrossRef

  45. 45
    Gregory A. Michelotti, Mariana V. Machado, Anna Mae Diehl, NAFLD, NASH and liver cancer, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 656

    CrossRef

  46. 46
    Roslyn Vongsuvanh, David van der Poorten, Jacob George, Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific, Hepatology International, 2013, 7, S2, 823

    CrossRef

  47. 47
    Jacob Alexander, Michael Torbenson, Tsung-Teh Wu, Matthew M. Yeh, Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: A clinical and pathological study, Journal of Gastroenterology and Hepatology, 2013, 28, 5
  48. You have free access to this content48
    Teruki Miyake, Teru Kumagi, Shinya Furukawa, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji, Non-alcoholic fatty liver disease: Factors associated with its presence and onset, Journal of Gastroenterology and Hepatology, 2013, 28,
  49. 49
    Vincent Wai-Sun Wong, Nonalcoholic fatty liver disease in Asia: A story of growth, Journal of Gastroenterology and Hepatology, 2013, 28, 1
  50. 50
    Howard C. Masuoka, Naga Chalasani, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals, Annals of the New York Academy of Sciences, 2013, 1281, 1
  51. 51
    Ijin Joo, Jeong Min Lee, Jeong Hee Yoon, Ja Jun Jang, Joon Koo Han, Byung Ihn Choi, Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging—An Experimental Study in a Rabbit Model, Radiology, 2013, 122506

    CrossRef

  52. 52
    J. F. L. Cobbold, S. Raveendran, C. M. Peake, Q. M. Anstee, M. S. Yee, M. R. Thursz, Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience, Frontline Gastroenterology, 2013, 4, 4, 263

    CrossRef

  53. 53
    Siddharth Verma, Donald Jensen, John Hart, Smruti R. Mohanty, Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD), Liver International, 2013, 33, 9
  54. 54
    Srinevas K. Reddy, Omar Hyder, J. Wallis Marsh, Georgios C. Sotiropoulos, Andreas Paul, Sorin Alexandrescu, Hugo Marques, Carlo Pulitano, Eduardo Barroso, Luca Aldrighetti, David A. Geller, Christine Sempoux, Vlad Herlea, Irinel Popescu, Robert Anders, Laura Rubbia-Brandt, Jean-Francois Gigot, Giles Mentha, Timothy M. Pawlik, Prevalence of Nonalcoholic Steatohepatitis Among Patients with Resectable Intrahepatic Cholangiocarcinoma, Journal of Gastrointestinal Surgery, 2013, 17, 4, 748

    CrossRef

  55. 55
    Rong Li, Lingyuan Xu, Tao Liang, Yongwen Li, Shijun Zhang, Xiaoqun Duan, Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function, Food and Chemical Toxicology, 2013, 52, 69

    CrossRef

  56. 56
    Myriam Auclair, Guillaume Martel, Real Lapointe, Successful orthotopic liver transplantation after biliopancreatic diversion with duodenal switch, Surgery for Obesity and Related Diseases, 2013, 9, 3, e46

    CrossRef

  57. 57
    Csilla Balassy, Diana Feier, Markus Peck-Radosavljevic, Friedrich Wrba, Stephan Witoszynskyj, Berthold Kiefer, Gert Reiter, Yongming Dai, Ahmed Ba-Ssalamah, Susceptibility-weighted MR Imaging in the Grading of Liver Fibrosis: A Feasibility Study, Radiology, 2013, 122440

    CrossRef

  58. 58
    Samer Tohme, Daniel Sukato, Hui-Wei Chen, Nikhil Amesur, Albert B. Zajko, Abhinav Humar, David A. Geller, James W. Marsh, Allan Tsung, Yttrium-90 Radioembolization as a Bridge to Liver Transplantation: A Single-Institution Experience, Journal of Vascular and Interventional Radiology, 2013, 24, 11, 1632

    CrossRef

  59. You have free access to this content59
    J. Shen, H. L.-Y. Chan, G. L.-H. Wong, A. W.-H. Chan, P. C.-L. Choi, H.-Y. Chan, A. M.-L. Chim, D. K.-W. Yeung, J. Yu, W. C.-W. Chu, V. W.-S. Wong, Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers, Alimentary Pharmacology & Therapeutics, 2012, 36, 11-12
  60. 60
    Donna L. White, Fasiha Kanwal, Hashem B. El–Serag, Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review, Clinical Gastroenterology and Hepatology, 2012, 10, 12, 1342

    CrossRef

  61. 61
    Hayato Hikita, Takahiro Kodama, Satoshi Shimizu, Wei Li, Minoru Shigekawa, Satoshi Tanaka, Atsushi Hosui, Takuya Miyagi, Tomohide Tatsumi, Tatsuya Kanto, Naoki Hiramatsu, Eiichi Morii, Norio Hayashi, Tetsuo Takehara, Bak deficiency inhibits liver carcinogenesis: A causal link between apoptosis and carcinogenesis, Journal of Hepatology, 2012, 57, 1, 92

    CrossRef

  62. 62
    Garfield A. Grandison, Paul Angulo, Can Nash Be Diagnosed, Graded, and Staged Noninvasively?, Clinics in Liver Disease, 2012, 16, 3, 567

    CrossRef

  63. 63
    Z. Permutt, T.-A. Le, M. R. Peterson, E. Seki, D. A. Brenner, C. Sirlin, R. Loomba, Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD, Alimentary Pharmacology & Therapeutics, 2012, 36, 1
  64. 64
    Luc Tappy, Kim-Anne Lê, Does fructose consumption contribute to non-alcoholic fatty liver disease?, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 6, 554

    CrossRef

  65. You have free access to this content65
    C. D. Byrne, Dorothy Hodgkin Lecture 2012 Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management, Diabetic Medicine, 2012, 29, 9
  66. 66
    Thuy-Anh Le, Joshua Chen, Christopher Changchien, Michael R. Peterson, Yuko Kono, Heather Patton, Benjamin L. Cohen, David Brenner, Claude Sirlin, Rohit Loomba, Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial , Hepatology, 2012, 56, 3
  67. 67
    Chiara Gabbi, Marco Bertolotti, Claudia Anzivino, Daria Macchioni, Marina Del Puppo, Matteo Ricchi, Francesca Carubbi, Enrico Tagliafico, Dante Romagnoli, Maria Rosaria Odoardi, Paola Loria, Luisa Losi, Nicola Carulli, Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease, Digestive and Liver Disease, 2012, 44, 12, 1018

    CrossRef

  68. 68
    Praveen Guturu, Andrea Duchini, Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity, Insulin Resistance and Mechanisms of Hepatotoxicity, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  69. 69
    Shelley E. Keating, Daniel A. Hackett, Jacob George, Nathan A. Johnson, Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis, Journal of Hepatology, 2012, 57, 1, 157

    CrossRef

  70. 70
    Dawn M. Torres, Christopher D. Williams, Stephen A. Harrison, Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, 2012, 10, 8, 837

    CrossRef

  71. 71
    Javier Ampuero, Manuel Romero-Gómez, Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular, Gastroenterología y Hepatología, 2012, 35, 8, 585

    CrossRef

  72. 72
    Vincent Wai-Sun Wong, Julien Vergniol, Grace Lai-Hung Wong, Juliette Foucher, Anthony Wing-Hung Chan, Faiza Chermak, Paul Cheung-Lung Choi, Wassil Merrouche, Shirley Ho-Ting Chu, Sophie Pesque, Henry Lik-Yuen Chan, Victor de Lédinghen, Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease, The American Journal of Gastroenterology, 2012, 107, 12, 1862

    CrossRef

  73. 73
    Geoffrey C. Farrell, Derrick van Rooyen, Lay Gan, Shivrakumar Chitturi, NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications, Gut and Liver, 2012, 6, 2, 149

    CrossRef

  74. 74
    Ana C. TUYAMA, Charissa Y. CHANG, Non-alcoholic fatty liver disease, Journal of Diabetes, 2012, 4, 3
  75. 75
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 397

    CrossRef

  76. 76
    Srinevas K. Reddy, Jennifer L. Steel, Hui-Wei Chen, David J. DeMateo, Jon Cardinal, Jaideep Behari, Abhinav Humar, J. Wallis Marsh, David A. Geller, Allan Tsung, Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease, Hepatology, 2012, 55, 6
  77. 77
    Suzanne E. Mahady, Germaine Wong, Jonathan C. Craig, Jacob George, Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis, Hepatology, 2012, 56, 6
  78. 78
    Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim, Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome, The Korean Journal of Internal Medicine, 2012, 27, 1, 47

    CrossRef

  79. 79
    Kenneth Cusi, Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications, Gastroenterology, 2012, 142, 4, 711

    CrossRef

  80. 80
    Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, The American Journal of Gastroenterology, 2012, 107, 6, 811

    CrossRef

  81. 81
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 2012, 142, 7, 1592

    CrossRef

  82. You have free access to this content82
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 2012, 55, 6
  83. 83
    Mangesh R. Pagadala, Arthur J. McCullough, The Relevance of Liver Histology to Predicting Clinically Meaningful Outcomes in Nonalcoholic Steatohepatitis, Clinics in Liver Disease, 2012, 16, 3, 487

    CrossRef

  84. 84
    Lin Xie, Joji Yui, Akiko Hatori, Tomoteru Yamasaki, Katsushi Kumata, Hidekatsu Wakizaka, Yuichiro Yoshida, Masayuki Fujinaga, Kazunori Kawamura, Ming-Rong Zhang, Translocator protein (18kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease, Journal of Hepatology, 2012, 57, 5, 1076

    CrossRef

  85. 85
    Srinevas K. Reddy, J. Wallis Marsh, Patrick R. Varley, Brady K. Mock, Kapil B. Chopra, David A. Geller, Allan Tsung, Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: A case-control study, Hepatology, 2012, 56, 6
  86. 86
    W.-C. Wu, C.-Y. Wu, Y.-J. Wang, H.-H. Hung, H.-I. Yang, W.-Y. Kao, C.-W. Su, J.-C. Wu, W.-L. Chan, H.-C. Lin, F.-Y. Lee, S.-D. Lee, Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects, Alimentary Pharmacology & Therapeutics, 2012, 36, 6
  87. 87
    Scott C. Leverage, Paul Angulo, Nonalcoholic Fatty Liver Disease: What Are the Odds Your Patient Will Get a Transplant?, Clinical Gastroenterology and Hepatology, 2011, 9, 8, 631

    CrossRef

  88. You have free access to this content88
    Mary E. Rinella, Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?, Hepatology, 2011, 54, 4
  89. 89
    Takeshi Okanoue, Kohichiroh Yasui, Yoshito Itoh, Non-Alcoholic Fatty Liver Disease in Japan,
  90. 90
    Janine Graham, Helen L. Reeves, Non-Alcoholic Fatty Liver Disease, Hepatocellular Cancer, and Other Cancers,
  91. 91
    Paul Angulo, The Natural History of NAFLD,
  92. 92
    Jonathon W. Schwake, Dawn M. Torres, Stephen A. Harrison, The Pointy End of the NAFLD Iceberg: Cirrhosis, Portal Hypertension, and Liver Failure,
  93. 93
    Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day, What is Non-Alcoholic Fatty Liver Disease (NAFLD), and Why is it Important?,